BrightSpring Health (BTSG) last issued guidance on February 27, 2026 for fiscal year 2026. The company guided revenue in the range of $14.45B - $15.00B for the period.
Compared to prior guidance, BrightSpring Health raised its revenue forecast from a prior range of $12.50B - $12.80B.
BrightSpring Health has issued 13 guidance updates between February 29, 2024 and February 27, 2026. During this period, the company raised its outlook 8 times and lowered it 1 time, providing investors with insight into management's evolving expectations.
Review all historical guidance issued by BrightSpring Health, including EPS and revenue forecasts across quarterly and annual periods.
The most recent guidance for BrightSpring Health (BTSG) was reported on February 27, 2026 for the fiscal year 2026. BrightSpring Health forecasted revenue between $14.45B and $15.00B for the period.
BrightSpring Health (BTSG) guided EPS in the range of $0.30 to $0.30 for Q3 2025. The consensus analyst EPS estimate is $0.27.
BrightSpring Health (BTSG) guided revenue in the range of $14.45B to $15.00B for the fiscal year 2026.
BrightSpring Health (BTSG) raised its revenue guidance from a prior range of $12.50B - $12.80B to $14.45B - $15.00B for the fiscal year 2026.
BrightSpring Health (BTSG) last issued guidance on February 27, 2026 for the fiscal year 2026.